Maze Therapeutics, Inc. (MAZE) vs Ocular Therapeutix, Inc. (OCUL)
- Maze Therapeutics, Inc. MAZE 27.53 +0.18%
- Ocular Therapeutix, Inc. OCUL 6.87 −6.91%
Maze Therapeutics, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.6B and $1.5B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −579.1%) and the lower return on invested capital (−112.4% vs 0.00%). Across the 13 metrics below, Maze Therapeutics, Inc. leads on 10 and Ocular Therapeutix, Inc. on 3.
Valuation
Profitability
| Metric | MAZE | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 87.11% | 65.16% |
| Operating margin | 0.00% | (603.04%) | 0.00% |
| Net margin | 0.00% | (579.10%) | 0.00% |
| Free cash flow margin | 0.00% | (490.07%) | 0.00% |
| Return on equity | (37.35%) | (72.99%) | (56.36%) |
| Return on assets | (31.99%) | (53.70%) | (48.04%) |
| Return on invested capital | (112.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack